Optiscan Imaging Ltd (ASX: OIL) is a global leader in the development, manufacture and commercialisation of endomicroscopic digital imaging technology solutions
Melbourne, Victoria
Joined May 2019
- Tweets112
- Following115
- Followers106
- Likes20
Good coverage in The West and @BullsNBearsWA today.
Learn more: optiscan.com
#digitalpatholology #imageguidedsurgery #singlecellimaging #imaginethepossibilities #thewest #optiscanimaging #invivage
A money trail is forming behind @Optiscan technology-based mission to tackle the scourge of #cancer, with revenue starting to stream into the company’s coffers from the lucrative Chinese health sector.
$OIL #BULLSNBEARSWA #ASX #MedTech @westaustralian
thewest.com.au/business/bull…
Delighted to be attending #CellBio23 in Boston. Looking forward to connecting with attendees and establishing new connections for our unique handheld, slide-free, non-destructive #viewnvivo single-cell imaging technology.
#seelifeconnected #CellBiology #CellBio #optiscanimaging
Learn more about our business, technology, and get glimpse into the future of digital pathology and precision surgery in this expert report from @stockhead
#optiscanimaging #digitalpathology #Robotics
Delighted to be collaborating with Design + Industry in developing our new product portfolio. With 260 industry awards over 35 years, we look forward to perfecting our new devices for clinicians, health systems and patients.
#imaginethepossibilities #digitalpathology
Optiscan Imaging Ltd wishes all our US colleagues, clinicians, partners, friends, and their families a wonderful #Thanksgiving.
We hope your day is filled with warmth, happiness, and the company of those closest to you.
Following news about a global shortage of pathologists, we have been featured in a special report by @StockheadAU today.
#optiscanimaging #digitalpathology #imaginethepossibilities
Read: stockhead.com.au/tech/optisc…
Optiscan Imaging Ltd has released its Quarterly Report and Appendix 4C for the quarter ended 30 September 2023.
Read: optiscan.com/investor/asx-an…
#optiscanimaging #asx
Delighted to announce a special report on our company in #stockhead today.
Learn more: optiscan.com
#optiscanimaging #digitalpathology #imaginethepossibilities
stockhead.com.au/health/diag…
Delighted to welcome Brendan Fafiani as our new Chief Operating Officer. Mr Fafiani will lead operations at our Melbourne headquarters, our operational planning, commercialisation strategy, customer and development efforts.
Read: optiscan.com/investor/asx-an…
#optiscanimaging #ASX
Delighted to announce the appointment of Tim Rowe and Shayra Leon as our new Business Development Managers for North America.
Read: optiscan.com/investor/asx-an…
#asx #optiscanimaging
Pleased to announce interim readout on our Breast Cancer Intraoperative Assessment Study, revealing excellent correlation between our real-time #CLE imaging and traditional histological analysis.
Read more: lnkd.in/gXYQ8uf2
#optiscanimaging #digitalpathology #asx
Further coverage by @westaustralian. Visit optiscan.com to learn more.
Optiscan Imaging has rounded out a dynamic year with a whopping 66 per cent revenue boost to nearly $1.7 million following the sale of its ViewnVivo research device to an American pharmaceutical company. #BULLSNBEARSWA bit.ly/3PlkSl9
Optiscan retweeted
#Medtech company @Optiscan_ has rounded out a dynamic year with a whopping 66 per cent revenue boost to nearly $1.7 million following the sale of its #ViewnVivo research device to an American pharmaceutical company.
$OIL @westaustralian @prolucid
thewest.com.au/business/bull…
We have released our Annual Report FY23, with revenues increasing to $1.68m (+66%) and net cash outflows decreasing from $3.8m to $3.2m. We thank all our collaborators, shareholders, and employees for their ongoing support & look forward to FY24.
optiscan.com/investor/asx-an…
Optiscan retweeted
#Medtech company @Optiscan_ secures $16.7m research and development funding
$OIL #OptiscanImaging #BULLSNBEARSWA #ASX #3DImaging #SaMD #DigitalPathology #ProlucidTechnologies
thewest.com.au/business/publ…
Further coverage in Bulls N' Bears today
#digitalpathology #imaginethepossibilities #AI #telepathology
#Medtech company @Optiscan_ secures $16.7m research and development funding
$OIL #OptiscanImaging #BULLSNBEARSWA #ASX #3DImaging #SaMD #DigitalPathology #ProlucidTechnologies
thewest.com.au/business/publ…
Pleased to announce our Entitlement Issue has successfully raised a total of $16.7m in funds, with $8.8m from Entitlement applications and $7.9m allocated to underwriters.
Read: optiscan.com/investor/asx-an…
#optiscanimaging #asx #DigitalPathology
Optiscan retweeted
Optiscan Imaging has been invited to present its remarkable confocal endomicroscopic medical imaging technology at two key international conferences in North and South America.
#BULLSNBEARSWA
bit.ly/3XQk8Hy
We are pleased to advise a study from our clinical research partnership with the Melbourne Dental School has been published in Fontiers in Oncology this week.
Read the paper below frontiersin.org/journals/onc…
Optiscan retweeted
ASX-listed @Optiscan_ has revealed a $16.7 million mission to fast-track the development and commercialisation of its revolutionary medical imagery devices.
$OIL #OptiscanImaging #BULLSNBEARSWA @westaustralian #ASX #Medtech #Healthcare thewest.com.au/business/publ…